Authors
Latest:
Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung CancerThis review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
Latest:
Guided Care and the Cost of Complex Healthcare: A Preliminary ReportThe early months of a cluster-randomized trial suggest that Guided Care is associated with a trend toward a net reduction in total healthcare expenditures.
Latest:
Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid TherapyThe increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.
Latest:
Long-Term Outcomes of Analogue Insulin Compared With NPH for Patients With Type 2 Diabetes MellitusThere were no significant differences in the risk of ambulatory care—sensitive condition hospitalization or mortality between patients who initiated analogue insulin compared with the neutral protamine Hagedorn.
Latest:
Can a Nationwide Media Campaign Affect Antibiotic Use?A nationwide media campaign aimed at parents was associated with reductions in the use of antibiotics for pediatric upper respiratory infections, otitis media, and pharyngitis.
Latest:
Chronic Disease Management in the COVID-19 EraIn the coronavirus disease 2019 (COVID-19) era, clinical registries and innovative virtual care delivery tools should be leveraged to engage populations in effective chronic disease management.
Latest:
The Patient-Driven Payment Model: Addressing Perverse Incentives, Creating New OnesThe Patient-Driven Payment Model addresses perverse incentives in Medicare’s previous payment system for skilled nursing facilities, but it includes new incentives that may be problematic.
Latest:
Comparing Quality of Care in the Medicare ProgramQuality measures showed large, though mixed, differences between Medicare fee-for-service and Medicare Advantage programs.
Latest:
Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
Latest:
Can Outpatient Pharmacy Data Identify Persons With Undiagnosed COPD?Algorithms based on managed care pharmacy data can efficiently identify persons at risk for undiagnosed chronic obstructive pulmonary disease.
Latest:
Outcomes Among Chronically Ill Adults in a Medical Home PrototypeThis study investigated healthcare quality, utilization, and costs among patients with common chronic illnesses in a patient-centered medical home prototype redesign.
Latest:
The Impact of Formulary Drug Exclusion Policies on Patients and Healthcare CostsThe authors review empirical evaluations of drug exclusion policies to examine their impact on patients and on healthcare costs.
Latest:
STABLE Results: Warfarin Home Monitoring Achieves Excellent INR ControlReal-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range.
Latest:
True "Meaningful Use": Technology Meets Both Patient and Provider NeedsA qualitative study of patient and provider perspectives regarding the after-visit summary and the patient portal features of the electronic health record.
Latest:
Medical Homes Require More Than an EMR and Aligned IncentivesPrimary care teams implementing medical homes experience professional role confusion and interpersonal conflict, and require effective administrative leadership to ensure success during this transition.
Latest:
Improving Endoscopy Completion: Effectiveness of an Interactive Voice Response SystemAn interactive voice response system is as effective as nurse phone calls for ensuring that patients attend appointments and are adequately prepared for endoscopy examinations.
Latest:
Medicaid Prior Authorization and Opioid Medication Abuse and OverdoseEnrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.
Latest:
Technologies Behind Biomarker Discovery and DevelopmentMetabolomics, Proteomics, and Epigenetics
Latest:
Did They Come to the Dance? Insurer Participation in ExchangesThis study analyzes the factors associated with insurer participation in the initial year of individual market exchanges created under the Affordable Care Act.
